Partnerships

White Label vs B2B2C in Supplements: Which Makes More Sense for Whom?

 · 5 min

Comparison between the white label model (private label) and the B2B2C model in supplements: when each one works, investment, margin, risks and expected ROI in 2026.

Brands and entrepreneurs in the supplements segment in 2026 face a clear strategic decision: build their own brand via white label (private label) or distribute via B2B2C platform with a network of professionals. The choice has profound implications for capital, time and risk. This comparison provides the essentials for an informed decision.

The essential distinction

Direct answer: White label is a model in which the company develops its own formulation (or outsources development), produces via contracted manufacturer, packages with its own visual identity, registers with regulatory bodies and distributes through its own channels. B2B2C is a model in which the existing brand (yours or a third party) uses a platform that connects to the professional channel to distribute via curation by physical educators. Investment, horizon, margin and risk are significantly different in the two. The choice depends on the company’s stage, available capital and strategic vision.

Profile of each model

White label (private label)

Who operates: entrepreneur/company that wants to build its own brand with total control.

Typical chain:

  1. Portfolio definition
  2. Formulation development (own laboratory or third party)
  3. Hiring a third-party manufacturer
  4. Packaging design and visual identity
  5. Regulatory registration (MAPA/ANVISA)
  6. Minimum production batch (often R$100-500k)
  7. Distribution (retail, own e-commerce, marketplaces, B2B)
  8. Brand Marketing

Typical initial investment: R$300k-2M for serious entry.

Horizon for ROI: 18-36 months.

Typical gross margin: 40-60% after COGS (product cost).

B2B2C

Who operates: existing brand (or individual professional) who wants to accelerate qualified distribution.

Typical chain:

  1. Existing brand with validated and regularized product
  2. Onboarding on a B2B2C platform
  3. Technical material to support the channel
  4. Activation of a professional network
  5. Operation (orders, logistics via the platform)
  6. Channel management

Typical initial investment: R$20-100k (ready product + material + onboarding).

Horizon for ROI: 6-18 months.

Typical gross margin: 15-25% after professional + platform commissions.

Comparison table

DimensionWhite labelB2B2C
Initial investmentHigh (R$ 300k+)Medium (R$ 20-100k)
Time to ROI18-36 meses6-18 meses
Margin per sale40-60% bruta15-25% após comissões
Control over productTotalPartial (depends on brand)
Regulatory riskAll yoursShared
ScalabilityDepends on operationDischarge via network
Brand asset buildingVery highAverage
Channel dependencyLow (various channels)High (chosen platform)
Market learning speedLowHigh

When white labeling makes more sense

Favorable contexts

Main risks

When B2B2C makes more sense

Favorable contexts

Main risks

Hybrid strategy: the two together

Some mature players operate both models simultaneously:

White label: own product distributed in physical retail, own e-commerce, marketplaces.

B2B2C: the same product (or complementary line) distributed via a network of professionals.

Advantages of the combination

Challenges

Hybrid strategy usually makes sense from the 2nd-3rd year of operation, after consolidation in one of the models.

Decisions at each stage

Year 0-1: which one to start

Year 1-2: Expand

Year 2-3: combine (if it makes sense)

Tracking metrics

For white label

For B2B2C

Common mistakes

White brand with insufficient capital. Locking up R$200k waiting 24 months breaks the bank.

B2B2C without real quality product. Platform can deliver channel, but bad product burns out quickly.

Compare unit margin separately. High margin on a white label can come with a high CAC; Lower margin in B2B2C can come with high volume.

Getting into B2B2C thinking it’s easy. Requires alignment with the channel, technical material, relationship management.

Forcing white label when B2B2C would comply. Disproportionate investment for the phase.

Ignoring white label regulations. Mistakes can be costly and time-consuming.

Key Takeaway Points


Additional reading:


Mega Suplementos delivers B2B2C infrastructure for brands that want to accelerate qualified distribution, with or without parallel white label operations. Talk to the team.

Partner brand?

Submit your details — we respond after curation.

Talk to the team
← Back to articles